SKI Market

Indian Indices

Sensex

82,276.07 50.15
( 0.06%)

Global Indices

Nasdaq

49,202.49 377.42
(0.77%)

Dow Jones

6,910.52 51.77
(0.75%)

Hang Seng

58,650.11 1,329.02
(2.32%)

Nikkei 225

10,802.86 122.27
(1.14%)

Forex

USD-INR

90.87 0.15
(0.16%)

EUR-INR

107.26 0.37
(0.35%)

GBP-INR

122.73 0.47
(0.39%)

JPY-INR

0.59 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Ipca Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524494

INE571A01038

291.9817605

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IPCALAB

38.48

38648.03

EPS(TTM)

Face Value()

Div & Yield %

39.59

0.26

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	6677.92	6166.46	5814.62	5438.30	5139.16	4367.43
Excise Duty	0.00	0.00	0.00	0.00	0.00	29.61
Net Sales	6677.92	6166.46	5814.62	5438.30	5139.16	4337.82
Other Income	71.29	111.29	111.19	52.92	62.24	64.69
Stock Adjustments	-128.43	55.19	-104.09	126.00	170.73	155.05
Total Income	6620.78	6332.94	5821.72	5617.22	5372.13	4557.56
EXPENDITURE :
Raw Materials	1764.88	2033.57	1964.94	1911.88	1753.21	1635.75
Power & Fuel Cost	235.60	253.33	277.21	237.44	201.48	196.82
Employee Cost	1479.34	1336.19	1193.39	1102.14	948.84	870.79
Other Manufacturing Expenses	367.61	356.81	311.74	279.03	225.25	198.30
Selling & Administrative Expenses	953.42	846.95	812.67	612.89	551.23	523.99
Miscellaneous Expenses	503.13	314.87	236.31	179.67	113.31	149.41
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	5303.98	5141.72	4796.26	4323.05	3793.32	3575.06
Operating Profit	1316.80	1191.22	1025.46	1294.17	1578.81	982.50
Interest	65.06	122.58	46.34	10.41	11.13	18.84
Gross Profit	1251.74	1068.64	979.12	1283.76	1567.68	963.66
Depreciation	251.97	246.48	228.63	209.65	187.72	178.69
Profit Before Tax	999.77	822.16	750.49	1074.11	1379.96	784.97
Tax	340.90	288.01	223.95	197.28	244.98	137.98
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	8.11	3.74	20.84	16.46	-5.79	-5.47
Reported Net Profit	650.76	530.41	505.70	860.37	1140.77	652.46
Extraordinary Items	-169.55	-69.52	17.51	7.86	8.34	10.86
Adjusted Net Profit	820.31	599.93	488.19	852.51	1132.43	641.60
Adjustment below Net Profit	-4.92	-1.39	-2.05	1.15	-0.16	-107.04
P & L Balance brought forward	4956.80	4478.52	4076.35	3316.31	2277.18	1752.53
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	101.48	50.74	101.48	101.48	101.48	20.77
P & L Balance carried down	5501.16	4956.80	4478.52	4076.35	3316.31	2277.18
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	400.00	400.00	400.00	400.00	400.00	250.00
Dividend Per Share(Rs)	4.00	4.00	4.00	4.00	8.00	5.00
Earnings Per Share-Unit Curr	25.65	20.91	19.93	33.91	89.93	51.64
Earnings Per Share(Adj)-Unit Curr	25.65	20.91	19.93	33.91	44.97	25.82
Book Value-Unit Curr	271.64	250.24	231.66	215.84	374.67	290.11
Book Value(Adj)-Unit Curr	271.64	250.24	231.66	215.84	187.34	145.06

82,276.07 50.15 ( 0.06%)

49,202.49 377.42 (0.77%)

6,910.52 51.77 (0.75%)

58,650.11 1,329.02 (2.32%)

10,802.86 122.27 (1.14%)

90.87 0.15 (0.16%)

107.26 0.37 (0.35%)

122.73 0.47 (0.39%)

0.59 0.00 (0.51%)